The influence of culture conditions on vasculitis and anaphylactoid shock induced by fungal pathogen Candida albicans cell wall extract in mice

Microbial Pathogenesis

Volumn 44, Issue 5, 2008, Pages 379-388

  Tada, Rui ^a   Nagi Miura, Noriko ^a   Adachi, Yoshiyuki ^a   Ohno, Naohito ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Anaphylactoid shock; Candida albicans; Culture conditions; Mannan; Vasculitis

Indexed keywords

ANTISERUM; CELL EXTRACT; MANNAN;

ANAPHYLACTIC SHOCK; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERITIS; ARTICLE; BIOLOGICAL ACTIVITY; CANDIDA ALBICANS; CELL CULTURE; CELL STRUCTURE; CELL WALL; CONTROLLED STUDY; CORONARY ARTERY; CULTURE MEDIUM; CYTOLOGY; FUNGAL CELL; FUNGAL VIRULENCE; FUNGUS CULTURE; MALE; MOUSE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPERATURE; VASCULITIS;

ANAPHYLAXIS; ANIMALS; CANDIDA ALBICANS; CELL EXTRACTS; CELL WALL; CORONARY VESSELS; CULTURE MEDIA; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MANNANS; MICE; SEROTYPING; SURVIVAL ANALYSIS; TEMPERATURE; VASCULITIS;

CANDIDA; CANDIDA ALBICANS; MUS;

EID: 42049100584     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2007.10.013     Document Type: Article

References (40)

1. Burns J.C., and Glode M.P. Kawasaki syndrome. Lancet 364 (2004) 533-544
2. Cimaz R., and Falcini F. An update on Kawasaki disease. Autoimmun Rev 2 (2003) 258-263
3. Akiyama T., and Yashiro K. Probable role of Streptococcus pyrogenes in Kawasaki disease. Eur J Pediatr 152 (1993) 82-92
4. Esper F., Shapiro E.D., Weibel C., Ferguson D., Landry M.L., and Kahn J.S. Association between a novel human coronavirus and Kawasaki disease. J Infect Dis 191 (2005) 499-502
5. Wang C.L., Wu Y.T., Liu C.A., Kuo H.C., and Yang K.D. Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J 24 (2005) 998-1004
6. Levy I., Shalit I., Birk E., Sirota L., Ashkenazi S., German B., et al. Candida endocarditis in neonates: report of five cases and review of the literature. Mycoses 49 (2006) 43-48
7. Rangel-Frausto M.S., Wiblin T., Blumberg H.M., Saiman L., Patterson J., Rinaldi M., et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 29 (1999) 253-258
8. Beck-Sague C., and Jarvis W.R. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 167 (1993) 1247-1251
9. Murata H., and Naoe S. Experimental Candida-induced arteritis in mice-relation to arteritis in Kawasaki disease. Prog Clin Biol Res 250 (1987) 523
10. Takahashi K., Oharaseki T., Wakayama M., Yokochi Y., Naoe S., and Murata H. Histopathological features of murine systemic vasculitis caused by Candida albicans extract-an animal model of Kawasaki disease. Inflamm Res 53 (2004) 72-77
11. Uchiyama M., Ohno N., Miura N.N., Adachi Y., Aizawa M.W., Tamura H., et al. Chemical and immunochemical characterization of limulus factor G-activating substance of Candida spp. FEMS Immunol Med Microbiol 24 (1999) 411-420
12. Nagi-Miura N., Shingo Y., Adachi Y., Ishida-Okawara A., Oharaseki T., Takahashi K., et al. Induction of coronary arteritis with administration of CAWS (Candida albicans water-soluble fraction) depending on mouse strains. Immunopharmacol Immunotoxicol 26 (2004) 527-543
13. Nagi-Miura N., Harada T., Shinohara H., Kurihara K., Adachi Y., Ishida-Okawara A., et al. Lethal and severe coronary arteritis in DBA/2 mice induced by fungal pathogen, CAWS, Candida albicans water-soluble fraction. Atherosclerosis 186 (2006) 310-320
14. Kurihara K., Shingo Y., Miura N.N., Naoe S., Usui Y., Adachi Y., et al. Effect of CAWS, a mannoprotein-beta-glucan complex of Candida albicans, on leukocyte, endothelial cell, and platelet functions in vitro. Biol Pharm Bull 26 (2003) 233-240
15. Tada R., Miura N.N., Adachi Y., and Ohno N. Candida albicans derived fungal PAMPS, CAWS, water soluble mannoprotein-beta-glucan complex shows similar immunotoxicological activity with bacterial endotoxin from Escherichia coli O9. Biol Pharm Bull 29 (2006) 240-246
16. Shinohara H., Miura N.N., Ishibashi K., Adachi Y., Ishida-Okawara A., Oharaseki T., et al. Beta-mannosyl linkages negatively regulate anaphylaxis and vasculitis in mice, induced by CAWS, fungal PAMPS composed of mannoprotein-beta-glucan complex secreted by Candida albicans. Biol Pharm Bull 29 (2006) 1854-1861
17. Masuoka J. Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges. Clin Microbiol Rev 17 (2004) 281-310
18. Nelson R.D., Shibata N., Podzorski R.P., and Herron M.J. Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action. Clin Microbiol Rev 4 (1991) 1-19
19. Poulain D., and Jouault T. Candida albicans cell wall glycans, host receptors and responses: elements for a decisive crosstalk. Curr Opin Microbiol 7 (2004) 342-349
20. Jouault T., Fradin C., Trinel P.A., Bernigaud A., and Poulain D. Early signal transduction induced by Candida albicans in macrophages through shedding of a glycolipid. J Infect Dis 178 (1998) 792-802
21. Jouault T., Lepage G., Bernigaud A., Trinel P.A., Fradin C., Wieruszeski J.M., et al. Beta-1,2-linked oligomannosides from Candida albicans act as signals for tumor necrosis factor alpha production. Infect Immun 63 (1995) 2378-2381
22. Fradin C., Jouault T., Mallet A., Mallet J.M., Camus D., Sinay P., et al. Beta-1,2-linked oligomannosides inhibit Candida albicans binding to murine macrophage. J Leukoc Biol 60 (1996) 81-87
23. Li R.K., and Cutler J.E. Chemical definition of an epitope/adhesin molecule on Candida albicans. J Biol Chem 268 (1993) 18293-18299
24. Miyakawa Y., Kuribayashi T., Kagaya K., Suzuki M., Nakase T., and Fukazawa Y. Role of specific determinants in mannan of Candida albicans serotype A in adherence to human buccal epithelial cells. Infect Immun 60 (1992) 2493-2499
25. Okawa Y., Goto K., Nemoto S., Akashi M., Sugawara C., Hanzawa M., et al. Antigenicity of cell wall mannans of Candida albicans NIH B-792 (serotype B) strain cells cultured at high temperature in yeast extract-containing sabouraud liquid medium. Clin Diagn Lab Immunol 3 (1996) 331-336
26. Kobayashi H., Takahashi S., Shibata N., Miyauchi M., Ishida M., Sato J., et al. Structural modification of cell wall mannans of Candida albicans serotype A strains grown in yeast extract-Sabouraud liquid medium under acidic conditions. Infect Immun 62 (1994) 968-973
27. Shibata N., Suzuki A., Kobayashi H., and Okawa Y. Chemical structure of the cell-wall mannan of Candida albicans serotype A and its difference in yeast and hyphal forms. Biochem J 404 (2007) 365-372
28. 13C nuclear magnetic resonance chemical shifts of β-1,2-linked mannooligosaccharides isolated from the phosphomannan of the pathogenic yeast Candida albicans NIH B-792 strain. Arch Biochem Biophys 302 (1993) 113-117
29. Kobayashi H., Komido M., Watanabe M., Matsuda K., Suzuki M., Ikeda T., et al. Structure of cell wall mannan of Candida kefyr IFO 0586. Infect Immun 62 (1994) 4425-4431
30. Kind L.S., Kaushal P.K., and Drury P. Fatal anaphylaxis-like reaction induced by yeast mannans in nonsensitized mice. Infect Immun 5 (1972) 180-182
31. Garner R.E., and Hudson J.A. Intravenous injection of Candida-derived mannan results in elevated tumor necrosis factor alpha levels in serum. Infect Immun 64 (1996) 4561-4566
32. Dalle F., Jouault T., Trinel P.A., Esnault J., Mallet J.M., d'Athis P., et al. Beta-1,2- and alpha-1,2-linked oligomannosides mediate adherence of Candida albicans blastospores to human enterocytes in vitro. Infect Immun 71 (2003) 7061-7068
33. Fradin C., Poulain D., and Jouault T. Beta-1,2-linked oligomannosides from Candida albicans bind to a 32-kilodalton macrophage membrane protein homologous to the mammalian lectin galectin-3. Infect Immun 68 (2000) 4391-4398
34. Jouault T., El Abed-El Behi M., Martinez-Esparza M., Breuilh L., Trinel P.A., Chamaillard M., et al. Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J Immunol 177 (2006) 4679-4687
35. Kohatsu L., Hsu D.K., Jegalian A.G., Liu F.T., and Baum L.G. Galectin-3 induces death of Candida species expressing specific beta-1,2-linked mannans. J Immunol 177 (2006) 4718-4726
36. Shepherd M.G., and Sullivan P.A. The production and growth characteristics of yeast and mycelial forms of Candida albicans in continuous culture. J Gen Microbiol 93 (1976) 361-370
37. Fukazawa Y., Shinoda T., and Tsuchiya T. Response and specificity of antibodies for Candida albicans. J Bacteriol 95 (1968) 754-763
38. Tsuchiya T., Fukazawa Y., and Kawakita S. A method for the rapid identification of the genus Candida. Mycopathol Mycol Appl 10 (1959) 191-206
39. Suzuki S., and Suzuki M. Structural investigation of mannans of medically relevant Candida species; determination of chemical structures of antigenic factors, 1, 4, 5, 6, 9 and 13b. Fungal Cells Biodefense Mech (1997) 1-15
40. Griesinger C., Otting G., Wuthrich K., and Ernst R.R. Clean TOCSY for proton spin system identification in macromolecules. J Am Chem Soc 110 (1988) 7870-7872